{{Rsnum
|rsid=2236256
|Gene=OPRM1
|Chromosome=6
|position=154157305
|Orientation=plus
|GMAF=0.4711
|Gene_s=IPCEF1,OPRM1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 31.9 | 46.0 | 22.1
| HCB | 21.2 | 51.8 | 27.0
| JPT | 24.8 | 49.6 | 25.7
| YRI | 23.3 | 49.3 | 27.4
| ASW | 26.3 | 54.4 | 19.3
| CHB | 21.2 | 51.8 | 27.0
| CHD | 23.9 | 51.4 | 24.8
| GIH | 16.8 | 46.5 | 36.6
| LWK | 40.9 | 40.9 | 18.2
| MEX | 12.1 | 51.7 | 36.2
| MKK | 34.6 | 51.3 | 14.1
| TSI | 27.5 | 56.9 | 15.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=24292274
|Title=A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia
}}{{PMID Auto
|PMID=22882391
|Title=Genetic association of GABA-A receptor alpha-2 and mu opioid receptor with cocaine cue-reactivity: evidence for inhibitory synaptic neurotransmission involvement in cocaine dependence.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}